| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |